AIM Vaccine Co., Ltd. Class H (HK:6660)
:6660
Want to see HK:6660 full AI Analyst Report?
Total Valuation
AIM Vaccine Co., Ltd. Class H has a market cap or net worth of HK$2.71B. The enterprise value is HK$3.87B.
Market CapHK$2.71B
Enterprise ValueHK$3.87B
Share Statistics
AIM Vaccine Co., Ltd. Class H has 507,673,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding507,673,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AIM Vaccine Co., Ltd. Class H’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -4.05%.
Return on Equity (ROE)-0.24
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-4.05%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee759.40K
Profits Per Employee-499.39K
Employee Count1,535
Asset Turnover0.18
Inventory Turnover1.17
Valuation Ratios
The current PE Ratio of AIM Vaccine Co., Ltd. Class H is ―. AIM Vaccine Co., Ltd. Class H’s PEG ratio is -0.04.
PE Ratio―
PS Ratio3.03
PB Ratio1.28
Price to Fair Value1.28
Price to FCF-20.59
Price to Operating Cash Flow34.09
PEG Ratio-0.04
Income Statement
In the last 12 months, AIM Vaccine Co., Ltd. Class H had revenue of 1.17B and earned -675.46M in profits. Earnings per share was -0.55.
Revenue1.17B
Gross Profit760.20M
Operating Income-202.49M
Pretax Income-746.72M
Net Income-675.46M
EBITDA-89.41M
Earnings Per Share (EPS)-0.55
Cash Flow
In the last 12 months, operating cash flow was 67.47M and capital expenditures -238.87M, giving a free cash flow of -171.39M billion.
Operating Cash Flow67.47M
Free Cash Flow-171.39M
Free Cash Flow per Share-0.34
Dividends & Yields
AIM Vaccine Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.46
52-Week Price Change-45.06%
50-Day Moving Average2.63
200-Day Moving Average3.53
Relative Strength Index (RSI)36.59
Average Volume (3m)1.38M
Important Dates
AIM Vaccine Co., Ltd. Class H upcoming earnings date is Sep 2, 2026, TBA (Not Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
AIM Vaccine Co., Ltd. Class H as a current ratio of 0.66, with Debt / Equity ratio of 63.65%
Current Ratio0.66
Quick Ratio0.55
Debt to Market Cap0.49
Net Debt to EBITDA-15.49
Interest Coverage Ratio-3.59
Taxes
In the past 12 months, AIM Vaccine Co., Ltd. Class H has paid -22.24M in taxes.
Income Tax-22.24M
Effective Tax Rate0.03
Enterprise Valuation
AIM Vaccine Co., Ltd. Class H EV to EBITDA ratio is -54.96, with an EV/FCF ratio of -28.67.
EV to Sales4.22
EV to EBITDA-54.96
EV to Free Cash Flow-28.67
EV to Operating Cash Flow72.83
Balance Sheet
AIM Vaccine Co., Ltd. Class H has HK$384.72M in cash and marketable securities with HK$1.76B in debt, giving a net cash position of -HK$1.37B billion.
Cash & Marketable SecuritiesHK$384.72M
Total DebtHK$1.76B
Net Cash-HK$1.37B
Net Cash Per Share-HK$2.70
Tangible Book Value Per ShareHK$1.55
Margins
Gross margin is 65.22%, with operating margin of -17.37%, and net profit margin of -57.95%.
Gross Margin65.22%
Operating Margin-17.37%
Pretax Margin-64.06%
Net Profit Margin-57.95%
EBITDA Margin-7.67%
EBIT Margin-17.83%
Analyst Forecast
The average price target for AIM Vaccine Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.18%
EPS Growth Forecast-142.22%